Not applicableStudy completedNCT01985828
What this trial is testing
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Who this might be right for
Prostate Adenocarcinoma
Wake Forest University Health Sciences 83